Related Experiment Video
Updated: Feb 8, 2026

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
Unlicensed and Off-Label Medication Use in Pediatric and Neonatal Intensive Care Units: No Change Over a Decade
Hadar Nir-Neuman1, Ibrahim Abu-Kishk2, Michal Toledano3
1Pediatric Division, Assaf Harofeh Medical Center, Affiliated to Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Insights
Pediatric intensive care units (PICU) and neonatal intensive care units (NICU) show high rates of off-label and unlicensed medication use. Despite regulatory efforts, unlicensed drug prescriptions in PICUs have increased since 2002.
Area of Science:
- Pediatric Pharmacology
- Neonatal Pharmacology
- Drug Utilization Research
Background:
- Many medications used in pediatric populations are not formally evaluated for this age group, leading to off-label and unlicensed prescriptions.
- This practice poses potential risks due to a lack of age-specific pharmacokinetic and pharmacodynamic data.
Purpose of the Study:
- To assess the current prevalence of unlicensed and off-label medication use in neonatal intensive care units (NICU) and pediatric intensive care units (PICU).
- To compare current prescribing patterns with data from a similar study conducted in 2002.
Main Methods:
- A 2-month prospective study recorded all drugs prescribed to patients in NICU (n=134) and PICU (n=56).
- Medications were classified by patient age, license status, indication, and administration details.
- Data were compared with a 2002 study from the same units.
Main Results:
- In the NICU, 64.8% of prescriptions were off-label and 5.9% were unlicensed. 96.3% of neonates received at least one off-label medication.
- In the PICU, 43.8% of prescriptions were off-label and 3.4% were unlicensed. 90.5% of PICU patients received at least one off-label or unlicensed medication.
- While off-label use remained similar, unlicensed medication use decreased in NICU but increased significantly in PICU (0% in 2002 to 3.4% in 2016).
Conclusions:
- The study confirms a high prevalence of off-label and unlicensed medication use in NICU and PICU settings.
- Despite regulatory efforts, the use of unlicensed medications in PICUs has unexpectedly increased compared to 2002 data.
- Continued monitoring and research are essential to ensure safe and effective medication use in critically ill children.
Introduction:
Many of the medications prescribed to children are off-label and/or unlicensed because pharmacologic evaluations have not been performed in this age group.
Methods:
All drugs prescribed to patients admitted to the neonatal intensive care units (NICU) (n = 134) and pediatric intensive care units (PICU) (n = 56) during a 2-month observation period were recorded and classified according to patient age, drug license status, indicated use, and typical dosing, frequency and way of administration. Results were compared with prior data collected in 2002, from the same units.
Results:
In the NICU, among the 1064 prescriptions for 49 medications, 312 (29.2%) were licensed and 63 (5.9%) unlicensed, and 693 (64.8%) were off-label use. For the neonates, 23.9% and 96.3% received at least one unlicensed medication and one off-label medication, respectively. While the difference in off-label use between the two time periods was not statistically significant, unlicensed medications were less frequently prescribed in 2016 (5.9 versus 16.6%, p = 0.001). Regarding the PICU, among the 388 prescriptions for 75 medications, 205 (52%) were licensed and 13 (3.4%) unlicensed, and 170 (43.8%) were off-label. In contrast, in 2002, none of the medications prescribed were unlicensed (p = 0.001). The number of off-label medications (41%) and number of PICU patients receiving at least one unlicensed/off-label medication in these two time periods (88.7% versus 90.5% for 2016 and 2002, respectively) were similar.
Conclusions:
The current study confirms the high prevalence of unlicensed and off-label drug use in a PICU and NICU setting. Compared with a similar study conducted in the same PICU in 2002, despite regulatory efforts conducted in this area, the prevalence of unlicensed medications was surprisingly higher.
More Related Videos
Related Concept Videos
Measurement: Derived Units
Global Climate Change
Measurement: Standard Units
Sound Intensity
Inhaled Medications
Rates of Change

